Big Pharma’s Big Moves in 2025: A Pharmacist’s Perspective
This year started with a bang for pharmaceutical mergers and acquisitions (M&A). Johnson & Johnson made the largest deal of […]
This year started with a bang for pharmaceutical mergers and acquisitions (M&A). Johnson & Johnson made the largest deal of […]
Lindus Health and Quotient Sciences have joined forces to make it easier to find patients for medical studies and speed
On Tuesday, a new drug called Exdensur was approved by the FDA. This drug is made by a company called
The Biosecure Act is moving forward after being approved by the U.S. House as part of the National Defense Authorization
A company called DBV Technologies announced that their peanut allergy patch, Viaskin, worked well in a recent trial. This is
Johnson & Johnson has received FDA approval for a new treatment called Rybrevant Faspro. This treatment is for people with
NADMED, a Finnish biotech company, has introduced the NADMED Award 2026 to foster new findings in the study of metabolomics.
Genfit has shared positive early results from their phase 1b clinical trial testing a new drug, GNS561, combined with a
Today, we have updates from Bristol Myers Squibb, Novartis, Agios Pharmaceuticals, and news about a proposed new framework by the
The world of drug development is changing, and China’s booming biotechnology industry is a big part of that. Over the